Table 1.
The recorded inhibition zones of dichloromethane or ethyl acetate extracts of B. haynesii isolate MZ922052 against various clinical and standard bacterial isolates
| Mean zone of inhibition (mm) ± SD | ||
|---|---|---|
| Tested Microorganisms | Dichloromethane extract | Ethyl acetate extract |
| Clinical isolates | ||
| SE1, SE2, SE3 | 11 ± 0.5 | 16 ± 1.0 |
| VRSA1, VRSA2, VRSA3 | 12 ± 0.5 | 14 ± 1.0 |
| MDR EC1 | 11 ± 0.5 | 11 ± 0.5 |
| MDR EC2 | 12 ± 1.0 | 12 ± 1.0 |
| MDR KP1 | 12 ± 1.0 | 13 ± 0.5 |
| MDR KP2 | 11 ± 1.0 | 14 ± 1.0 |
| MDR KP3 | 11 ± 1.0 | 14 ± 1.0 |
| CA1 | 12 ± 0.5 | 11 ± 0.5 |
| Standard strains | ||
| C. albicans ATCC 10,231 | 12 ± 0.5 | 16 ± 1.0 |
| S. aureus ATCC 25,293 | 11 ± 1.0 | 13 ± 0.5 |
| E. coli ATCC 25,922 | 12 ± 1.0 | 14 ± 0.5 |
MDR, multidrug-resistant; VRSA, vancomycin resistant Staphylococcus aureus; EC, Escherichia coli, KP, Klebsiella pneumoniae, CA, Candida albicans.SE, Streptococcus epidermidis; SD, standard deviation